VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Cash and Bank History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹80 Cr | ₹68 Cr | ₹54 Cr | ₹50 Cr | ₹31 Cr |
What is the latest Cash and Bank ratio of VENUS REMEDIES ?
| Year | Cash and Bank |
|---|---|
| Mar2025 | ₹80 Cr |
| Mar2024 | ₹68 Cr |
| Mar2023 | ₹54 Cr |
| Mar2022 | ₹50 Cr |
| Mar2021 | ₹31 Cr |
How is Cash and Bank of VENUS REMEDIES Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2025 | ₹80 Cr | 17.64 | |
| Mar2024 | ₹68 Cr | 25.06 | |
| Mar2023 | ₹54 Cr | 8.04 | |
| Mar2022 | ₹50 Cr | 60.41 | |
| Mar2021 | ₹31 Cr | - | |
Compare Cash and Bank of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,016.9 Cr | -7.8% | 17.5% | 136% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,768.0 Cr | -2.7% | -2.2% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,385.0 Cr | -0.7% | -1.1% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,242.0 Cr | -0.8% | 0.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,093.0 Cr | -1.2% | -1.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,799.0 Cr | NA | 2.4% | 0.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -7.8% |
17.5% |
136% |
| SENSEX | -0.4% |
-0.2% |
2.9% |
You may also like the below Video Courses